» Articles » PMID: 36389170

MicroRNAs Associated with the Pathogenesis and Their Role in Regulating Various Signaling Pathways During Infection

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Despite more than a decade of active study, tuberculosis (TB) remains a serious health concern across the world, and it is still the biggest cause of mortality in the human population. Pathogenic bacteria recognize host-induced responses and adapt to those hostile circumstances. This high level of adaptability necessitates a strong regulation of bacterial metabolic characteristics. Furthermore, the immune reponse of the host virulence factors such as host invasion, colonization, and survival must be properly coordinated by the pathogen. This can only be accomplished by close synchronization of gene expression. Understanding the molecular characteristics of mycobacterial pathogenesis in order to discover therapies that prevent or resolve illness relies on the bacterial capacity to adjust its metabolism and replication in response to various environmental cues as necessary. An extensive literature details the transcriptional alterations of host in response to environmental stressors, macrophage infection, and human illness. Various studies have recently revealed the finding of several microRNAs (miRNAs) that are believed to play an important role in the regulatory networks responsible for adaptability and virulence in . We highlighted the growing data on the existence and quantity of several forms of miRNAs in the pathogenesis of , considered their possible relevance to disease etiology, and discussed how the miRNA-based signaling pathways regulate bacterial virulence factors.

Citing Articles

Unlocking the potential of miRNAs in detecting pulmonary tuberculosis: prospects and pitfalls.

Arya R, Kumar S, Vinetz J, Kim J, Chaurasia R Expert Rev Mol Med. 2024; 26:e32.

PMID: 39639643 PMC: 11629464. DOI: 10.1017/erm.2024.29.


Expression profiling & functional characterization of candidate miRNAs in serum exosomes among Indians with & without HIV-tuberculosis coinfection.

Kushwaha S, Yadav R, Kumar R, Kumar S, Chauhan D, Singh A Indian J Med Res. 2024; 159(6):653-662.

PMID: 39382473 PMC: 11463872. DOI: 10.25259/IJMR_1281_23.


Can We Exploit Inflammasomes for Host-Directed Therapy in the Fight against Infection?.

Cebani L, Mvubu N Int J Mol Sci. 2024; 25(15).

PMID: 39125766 PMC: 11311975. DOI: 10.3390/ijms25158196.


Amoebae as training grounds for microbial pathogens.

Price C, Hanford H, Al-Quadan T, Santic M, Shin C, Daas M mBio. 2024; 15(8):e0082724.

PMID: 38975782 PMC: 11323580. DOI: 10.1128/mbio.00827-24.


Oral Spirochete Intraoral Infection Reveals Unique miR-133a, miR-486, miR-126-3p, miR-126-5p miRNA Expression Kinetics during Periodontitis.

Aravindraja C, Jeepipalli S, Vekariya K, Botello-Escalante R, Chan E, Kesavalu L Int J Mol Sci. 2023; 24(15).

PMID: 37569480 PMC: 10418472. DOI: 10.3390/ijms241512105.


References
1.
Zheng D, Zang Y, Xu H, Wang Y, Cao X, Wang T . MicroRNA-214 promotes the calcification of human aortic valve interstitial cells through the acceleration of inflammatory reactions with activated MyD88/NF-κB signaling. Clin Res Cardiol. 2018; 108(6):691-702. DOI: 10.1007/s00392-018-1398-9. View

2.
Guicciardi M, Deussing J, Miyoshi H, Bronk S, Svingen P, Peters C . Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest. 2000; 106(9):1127-37. PMC: 301415. DOI: 10.1172/JCI9914. View

3.
Liang S, Song Z, Wu Y, Gao Y, Gao M, Liu F . MicroRNA-27b Modulates Inflammatory Response and Apoptosis during Infection. J Immunol. 2018; 200(10):3506-3518. DOI: 10.4049/jimmunol.1701448. View

4.
Vandenabeele P, Orrenius S, Zhivotovsky B . Serine proteases and calpains fulfill important supporting roles in the apoptotic tragedy of the cellular opera. Cell Death Differ. 2005; 12(9):1219-24. DOI: 10.1038/sj.cdd.4401719. View

5.
Zhang Y, Schiff D, Park D, Abounader R . MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET. PLoS One. 2014; 9(3):e91546. PMC: 3951453. DOI: 10.1371/journal.pone.0091546. View